Elitek
(Rasburicase)ApprovedProtein / enzyme
Rasburicase is used to treat high uric acid levels in the blood that can occur in cancer patients, especially those with blood cancers being treated with chemotherapy. It helps prevent kidney damage and other complications from uric acid buildup.[2] Elitek is currently approved and in use across 9 indications[4].[1]
Elitek is one of 233 small molecule programs targeting Arthritis. It is currently in Approved.
9
Indications
21
Total Trials
1
Active Trials
232
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
1774 competitors in Lymphoma
#DrugCompanyPhaseTrials
1Elitek
AAzienda U.S.L. 1 di Massa e Carrara
Approved
Velban
EEastern Cooperative Oncology Group
Preclinical
Zofran
NovartisPreclinical
Norvir
AbbViePreclinical
Wellcovorin
GGlaxo Dba Glaxosmithkline
Preclinical
Tafasitamab
IncytePreclinical
Emend
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Preclinical
Kenalog
BBausch Health Americas, Inc.
Preclinical
Decadron
QQuince Therapeutics S.p.A.
Preclinical
Systemic Therapy
Bristol-Myers SquibbPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Tumor Lysis Syndrome6 trials
Hyperuricemia4 trials
Leukemia2 trials
7 more indications
Acute Lymphoblastic Leukemia1 trial
Acute Leukemia1 trial
Arthritis1 trial
Rasburicase Treatment in Chronic Gouty Arthritis
Unknown status·SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Phase 4·NCT05312268·60 enrolled
Graft Versus Host Disease1 trial
Regulatory
FDA Approval Timeline[5]
Jul 12, 2002
ELITEK
BLA BLA103946
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Elitek drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Rasburicase. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]
Details